Badgley Phelps Wealth Managers, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Badgley Phelps Wealth Managers, LLC
- $3.76 Billion
- Q1 2024
A detailed history of Badgley Phelps Wealth Managers, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Badgley Phelps Wealth Managers, LLC holds 8,911 shares of REGN stock, worth $9.37 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
8,911Holding current value
$9.37 Million% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,424Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$9.39 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$9.01 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$8.12 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.09 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.89 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $113B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...